
Aimcare Pharmaceuticals Private Limited
About Aimcare Pharmaceuticals Private Limited
Data last updated:
Aimcare Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 01 November 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52100DL2016PTC307766.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Jiomax Healthcare Private Limited. It is led by directors Rajeev Kumar and Adarsh Rajpoot.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1st Floor Rz – F – 15 Gali No. 5 Mahavir Enclave 1, New Delhi, Delhi, India – 110045.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.86 Lakh, a decline of 84% compared to the previous year. For the same year it recorded a net loss of ₹13,154 (net margin -4.6%) and EBITDA of -₹13,154 (EBITDA margin -4.6%). Revenue has declined at a compounded annual rate (CAGR) of 46% over three years and 32% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Aimcare Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1st Floor Rz – F – 15 Gali No. 5 Mahavir Enclave 1, New Delhi, Delhi, India – 110045
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Aimcare Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aimcare Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Aimcare Pharmaceuticals Private Limited, buy the company report.
Financials of Aimcare Pharmaceuticals Private Limited
FY 2025 filings availableAimcare Pharmaceuticals Private Limited reported revenue of ₹2.86 Lakh (down 84% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 32% over five years, including a 84% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹13,154 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹13,154 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -4.6% | ||||
| Net Profit Margin | -4.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aimcare Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aimcare Pharmaceuticals Private Limited
Aimcare Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeev Kumar Also directs: Insurexlife Imf Private Limited | Director | 01 Nov 2016 | 10 Years 0 Months | Current |
| Adarsh Rajpoot | Director | 19 Apr 2023 | 3 Years 6 Months | Current |
Auditor
Aimcare Pharmaceuticals Private Limited is audited by GARG NIDHI & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GARG NIDHI & ASSOCIATES | FY 2017 | 018568C |
Shareholding
The shareholding of Aimcare Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Aimcare Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aimcare Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aimcare Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Aimcare Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aimcare Pharmaceuticals Private Limited has 5 board changes on record since 2016: 2 appointments and 3 cessations. The latest: Harish Kumar ceased to be Director on 24 May 2024.
Frequently asked questions
Aimcare Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in wholesale, within the trading industry. It was incorporated on 01 November 2016 (10+ years old) and is registered under CIN U52100DL2016PTC307766.
Aimcare Pharmaceuticals has 2 current directors:
- Rajeev Kumar - Director
- Adarsh Rajpoot - Director
The latest financial statements of Aimcare Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Aimcare Pharmaceuticals is U52100DL2016PTC307766. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aimcare Pharmaceuticals was incorporated on 01 November 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
Harish Kumar ceased to be Director on 24 May 2024. Saroj ceased to be Director on 24 May 2024. Vishaw Dev Rajput ceased to be Director on 24 May 2024. Aimcare Pharmaceuticals has 5 board changes on record in total.
The registered office of Aimcare Pharmaceuticals is at 1st Floor Rz – F – 15 Gali No. 5 Mahavir Enclave 1, New Delhi, Delhi, India – 110045.
Aimcare Pharmaceuticals operates in the trading industry, in the wholesale segment.
The compliance status of Aimcare Pharmaceuticals is compliant as of 07 July 2026. The company is actively filing with the Registrar of Companies.
Yes. Aimcare Pharmaceuticals was formerly known as Jiomax Healthcare Private Limited.

